Report Highlights
The global breathing circuits market reached $1.2 billion in 2022, should reach $1.3 billion by 2023 and $1.6 billion by 2028 with a compound annual growth rate (CAGR) of 5.1% during the forecast period of 2023-2028.
Report Includes
- 15 data tables and 9 additional tables
- An overview of the global markets for breathing circuits
- Analyses of global market trends, with data from 2021, 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
- Highlights of the market potential and characterization of breathing circuits market based on type, application, end-user, and region
- Discussion on innovation, technological advancements, and market drivers and restraints
- Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
- Company profiles of major players within the industry, including AMBU A/S, Beckton, Dickinson and Co., Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Ltd., and Medtronic plc
Report Scope
This report provides a comprehensive study of the global market for breathing circuits, both quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace and make informed business decisions regarding breathing circuits.
An in-depth global breathing circuits market analysis includes historical data and market projections on sales by product type, application, end-user and region. It describes the different types of breathing circuits tests and their current and historical market revenues. This report also categorizes the global breathing circuits market based on the region (North America, Europe, Asia-Pacific and the Rest of the World).
To provide a more robust understanding of the market, the report also profiles the competitive landscape, its key competitors and their respective market shares.
Report Synopsis
| Report Metrics | Details | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||
| Forecast period considered | 2023-2028 | ||||||||||
| Base year market size | $1.2 billion | ||||||||||
| Market size forecast | $1.6 billion | ||||||||||
| Growth rate | CAGR of 5.1% for the forecast period of 2023-2028 | ||||||||||
| Units considered | $ Millions | ||||||||||
| Segments covered | Product Type, Application, End User | ||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||
| Countries covered | U.S., Canada, Germany, France, U.K., Spain, Italy, Russia, Sweden, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, China, India, Japan, South Korea, Australia, Singapore, New Zealand, Taiwan, Malaysia, Thailand, Philippines, Indonesia, Latin America, Middle East and Africa | ||||||||||
| Key Market Drivers |
|
||||||||||
| Companies studied |
|
||||||||||
Frequently Asked Questions (FAQs)
- Medtronic plc
- Dragerwerk AG & Co. KGaA
- Becton, Dickinson and Company
- Ambu A/S
- Fisher & Paykel Healthcare Limited
- Airon Corporation
- Bio-Med Devices Inc.
- Flexicare Medical Ltd.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Anesthesia and Respiratory Devices: Global Markets
The global anesthesia and respiratory devices market should reach $36.2 billion by 2022 and more than $51 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.
Intensive Care Unit (ICU) Equipment: Global Markets
The global market for ICU equipment should grow from $7.4 billion in 2021 to $9.7 billion by 2026, at compound annual growth rate (CAGR) of 5.4% for the period of 2021-2026.
Healthcare-Acquired Infections: Devices, Pharmaceuticals, and Environmental Products
The global market HCAI Control should grow from $24.0 billion in 2021 to $36.2 billion by 2026, at compound annual growth rate (CAGR) of 8.6% for the period of 2021-2026.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More